AI assistant
DYNAVAX TECHNOLOGIES CORP — Director's Dealing 2023
May 31, 2023
32130_dirs_2023-05-31_5ca87cfe-c4de-49b2-9121-801a07b43c4f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2023-05-26
Reporting Person: CANO FRANCIS (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-26 | Common Stock | A | 5357 | $0.00 | Acquired | 31548 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-26 | Stock Options (Right to Buy) | $11.20 | A | 22500 | Acquired | 2030-05-25 | Common Stock (22500) | Direct |
Footnotes
F1: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of DVAX Common Stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company. The reporting person has reported prior awards of restricted stock units in Table II on Form 4. The total reported in Column 5 includes 5,357 newly awarded restricted stock units, 5,357 restricted stock units previously reported in Table II, and 20,834 shares of common stock.
F2: This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date.